Deficiency of AMPAR–Palmitoylation Aggravates Seizure Susceptibility
Masayuki Itoh(Cellular Therapeutics (United Kingdom)), Takashi Hayashi(Cellular Therapeutics (United Kingdom))
Cited by 42
Related Papers
LOX-1 mediates inflammatory activation of microglial cells through the p38-MAPK/NF-κB pathways under hypoxic-ischemic conditions
|Cell Communication and Signaling|2023|36
Limb-Clasping Response in NMDA Receptor Palmitoylation-Deficient Mice
|Molecular Neurobiology|2024|2
Chronic reduction of synaptic proteins in the epileptogenic lesion of patients with hippocampal sclerosis
|Frontiers in Molecular Neuroscience|2025|1